We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $12.4B
1-Year Est. Return 64.17%
This Fund
S&P 500
This Quarter Est. Return
+8.03%
1 Year Est. Return
+64.17%
3 Year Est. Return
+130.04%
5 Year Est. Return
+162.55%
10 Year Est. Return
+785.5%
AUM
$28.8B
AUM Growth
-$783M
Cap. Flow
-$2.41B
Cap. Flow %
-8.37%
Top 10 Hldgs %
9.51%
Holding
1,466
New
69
Increased
389
Reduced
586
Closed
155

Top Buys

Rank Stock Value
1
AXE
Anixter International Inc
AXE
+$64.8M
2
APAM icon
Artisan Partners
APAM
+$56.9M
3
DORM icon
Dorman Products
DORM
+$52.1M
4
RES icon
RPC Inc
RES
+$46.1M
5
NUS icon
Nu Skin
NUS
+$42.4M

Sector Composition

Rank Sector Weight
1 Industrials 26.03%
2 Technology 18.79%
3 Consumer Discretionary 15.93%
4 Financials 10.69%
5 Materials 8.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HXL icon
976
Hexcel
HXL
$6.91B
$1.97M 0.01%
47,500
EFX icon
977
Equifax
EFX
$19.6B
$1.95M 0.01%
24,150
INFO
978
DELISTED
IHS Markit Ltd. Common Shares
INFO
$1.93M 0.01%
73,100
MDSO
979
DELISTED
Medidata Solutions, Inc.
MDSO
$1.91M 0.01%
40,000
FIG
980
DELISTED
Fortress Investment Group Llc
FIG
$1.91M 0.01%
237,530
+28,400
+14% +$209K
JGW
981
DELISTED
J G WENTWORTH CO CL A COM STK (DE)
JGW
$1.9M 0.01%
178,000
BSTC
982
DELISTED
BioSpecifics Technologies Corp.
BSTC
$1.88M 0.01%
48,600
-38,000
-44% -$1.45M
CVSA
983
Covista Inc
CVSA
$4.3B
$1.86M 0.01%
39,200
-4,300
-10% -$202K
MOG.A icon
984
Moog Inc Class A
MOG.A
$11.3B
$1.85M 0.01%
25,000
CMD
985
DELISTED
Cantel Medical Corporation
CMD
$1.83M 0.01%
42,338
-4,100
-9% -$168K
NVCN
986
DELISTED
Neovasc Inc.
NVCN
$1.82M 0.01%
11
GWR
987
DELISTED
Genesee & Wyoming Inc.
GWR
$1.8M 0.01%
20,000
CMPR icon
988
Cimpress
CMPR
$2.03B
$1.8M 0.01%
24,000
MODN
989
DELISTED
MODEL N, INC.
MODN
$1.79M 0.01%
169,000
+5,414
+3% +$54.8K
IQNT
990
DELISTED
Inteliquent, Inc.
IQNT
$1.79M 0.01%
91,300
-8,700
-9% -$142K
GLBR
991
DELISTED
Global Brokerage, Inc. Class A Common Stock
GLBR
$1.78M 0.01%
10,764
-10,906
-50% -$1.78M
AXTI icon
992
AXT Inc
AXTI
$3.78B
$1.78M 0.01%
634,822
-1,741,096
-73% -$4.29M
UNTD
993
DELISTED
UNITED ONLINE INC COM NEW
UNTD
$1.77M 0.01%
121,871
+42,943
+54% +$540K
WRB icon
994
W.R. Berkley
WRB
$26.5B
$1.76M 0.01%
115,921
+17,212
+17% +$259K
UTEK
995
DELISTED
Ultratech Inc.
UTEK
$1.75M 0.01%
94,400
-147,840
-61% -$2.87M
JOY
996
DELISTED
Joy Global Inc
JOY
$1.73M 0.01%
37,100
+1,100
+3% +$56.3K
HRTX icon
997
Heron Therapeutics
HRTX
$59.6M
$1.72M 0.01%
+170,580
New +$1.39M
UVE icon
998
Universal Insurance Holdings
UVE
$1.23B
$1.71M 0.01%
83,800
+10,200
+14% +$178K
EMCI
999
DELISTED
EMC INS Group Inc
EMCI
$1.71M 0.01%
72,383
-9,600
-12% -$201K
CAKE icon
1000
Cheesecake Factory
CAKE
$4.81B
$1.71M 0.01%
33,900
-2,700
-7% -$128K

Similar funds

Royce & Associates's Q4 2014 Portfolio in Review

As of Q4 2014, Royce & Associates held 1,466 positions worth $28.8B, down 2.6% from $29.6B the previous quarter. Its ten largest holdings account for 9.5% of the portfolio.

Royce & Associates withdrew a net $2.41B in Q4 2014, closing 155 positions and reducing 586 holdings. Its most notable exit was Strategic Education, an estimated $42.5M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 26% of assets, up from 24% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Royce & Associates opened a new position in Avid Technology Inc worth $27.2M.

  • Royce & Associates's largest Q4 2014 buy was Avid Technology Inc: 1,911,784 shares worth $27.2M.
  • Royce & Associates added most to Anixter International Inc in Q4 2014, an estimated $64.8M increase.
  • Royce & Associates's biggest Q4 2014 reduction was Myriad Genetics, cutting an estimated $136M.
  • Royce & Associates fully exited Strategic Education in Q4 2014, selling an estimated $42.5M.
  • Royce & Associates's ten largest holdings make up 9.5% of its $28.8B portfolio in Q4 2014.
  • Royce & Associates opened 69 new positions and closed 155 in Q4 2014.
  • Royce & Associates's portfolio value fell 2.6% quarter-over-quarter to $28.8B.

Based on Royce & Associates's 13F filing for Q4 2014, filed 9 Feb 2015.